2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2203):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-I0348R
    Ticagrelor impurity 20 (Standard)
    Ticagrelor impurity 20 (Standard) is the analytical standard of Ticagrelor impurity 20 (HY-I0348). This product is intended for research and analytical applications.
    Ticagrelor impurity 20 (Standard)
  • HY-W076303
    1,11b-Dedihydrotetrabenazine
    1,11b-Dedihydrotetrabenazine is a drug impurity.
    1,11b-Dedihydrotetrabenazine
  • HY-Z0129
    Telmisartan impurity 2
    Telmisartan impurity 2 is an impurity of Telmisartan (HY-13955).
    Telmisartan impurity 2
  • HY-78903
    Monomethyl auristatin E intermediate-9
    Monomethyl auristatin E intermediate-9 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs).
    Monomethyl auristatin E intermediate-9
  • HY-W107225R
    Sorafenib impurity 6 (Standard)
    Sorafenib impurity 6 (Standard) is the analytical standard of Sorafenib impurity 6 (HY-W107225). This product is intended for research and analytical applications.
    Sorafenib impurity 6 (Standard)
  • HY-43488
    Tavarborol impurity 16
    Tavarborol impurity 16 is an impurity of Tavarborol.
    Tavarborol impurity 16
  • HY-I1083
    Bedaquinoline impurity 18
    		99.79%
    Bedaquinoline impurity 18 is an impurity of Bedaquinoline.
    Bedaquinoline impurity 18
  • HY-116284R
    Methyl β-D-glucopyranoside (Standard)
    Methyl β-D-glucopyranoside (Standard) is the analytical standard of Methyl β-D-glucopyranoside. This product is intended for research and analytical applications. Methyl β-D-glucopyranoside is used to synthesize natural glycophenolics via enzymatic caffeoylation.
    Methyl β-D-glucopyranoside (Standard)
  • HY-W675848
    N4-Bz-C-(S)-GNA phosphoramidite
    N4-Bz-C-(S)-GNA phosphoramidite is an important intermediate for the synthesis of nucleic acids and their analogs.
    N4-Bz-C-(S)-GNA phosphoramidite
  • HY-W721659
    Pirquinozol
    Pirquinozol (SQ 13,847) is an orally active anti-allergy agent. Pirquinozol is converted to the oxidation metabolite SQ 12,903, which can exert the maximum activity. Pirquinozol inhibits bronchospasm in rats.
    Pirquinozol
  • HY-113407C
    D-Fructose-6-phosphate disodium monohydrate
    D-Fructose-6-phosphate disodium monohydrate is an intermediate of Glycolysis. D-Fructose-6-phosphate disodium monohydrate is the precursor for the synthesis of amino sugars, such as galactosamine and glucosamine.
    D-Fructose-6-phosphate disodium monohydrate
  • HY-76816
    Paricalcitol impurity 9
    Paricalcitol impurity 9 is an impurity of Paricalcitol (HY-50919).
    Paricalcitol impurity 9
  • HY-Z0357
    Sitagliptin impurity 5
    Sitagliptin impurity 5 is an impurity of Sitagliptin (HY-13749).
    Sitagliptin impurity 5
  • HY-W027038
    Ethyl mandelate
    		99.73%
    Ethyl mandelate is an important intermediate in pharmaceutical synthesis. Ethyl mandelate can be synthesized by short-chain dehydrogenase/reductase (SDR).
    Ethyl mandelate
  • HY-W585886
    (E/Z)-FK-506 26,28-Allylic ester rearrangement impurity
    (E/Z)-FK-506 26,28-Allylic ester rearrangement impurity (FK506-A) is a Tacrolimus (HY-13756) impurity.
    (E/Z)-FK-506 26,28-Allylic ester rearrangement impurity
  • HY-23875R
    Metformin impurity 1 (Standard)
    Metformin impurity 1 (Standard) is the analytical standard of Metformin impurity 1 (HY-23875). This product is intended for research and analytical applications.
    Metformin impurity 1 (Standard)
  • HY-I0677
    Regorafenib impurity 8
    Regorafenib Impurity 8 is an impurity of Regorafenib (HY-10331).
    Regorafenib impurity 8
  • HY-I0875
    Ceritinib impurity 5
    Ceritinib impurity 5 is an impurity of Ceritinib (HY-15656).
    Ceritinib impurity 5
  • HY-Z4533
    Afatinib impurity 6
    Afatinib impurity 6 is an impurity of Afatinib (HY-10261).
    Afatinib impurity 6
  • HY-W015805
    3-Pyridylamide oxime
    3-Pyridylamide oxime is a synthetic intermediate useful for pharmaceutical synthesis.
    3-Pyridylamide oxime